Evidence map›Paper›PMID 27368642›Full record

ArticlePlant biotechnology journal2017

CRISPR-Cas9-mediated efficient directed mutagenesis and RAD51-dependent and RAD51-independent gene targeting in the moss Physcomitrella patens.

Cécile Collonnier, Aline Epert, Kostlend Mara, François Maclot, Anouchka Guyon-Debast, Florence Charlot, Charles White, Didier G Schaefer, Fabien Nogué

Abstract read
In one paragraph

Article in Plant biotechnology journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Recombinant Protein Drugs: A 2025 Update.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  3. The Importance of thePlants (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Extended Synaptotagmins ofPlants (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cécile CollonnierINRA Centre de Versailles-Grignon, IJPB (UMR1318), Versailles Cedex, France.
Aline EpertINRA Centre de Versailles-Grignon, IJPB (UMR1318), Versailles Cedex, France.
Kostlend MaraINRA Centre de Versailles-Grignon, IJPB (UMR1318), Versailles Cedex, France.
François MaclotINRA Centre de Versailles-Grignon, IJPB (UMR1318), Versailles Cedex, France.
Anouchka Guyon-DebastINRA Centre de Versailles-Grignon, IJPB (UMR1318), Versailles Cedex, France.
Florence CharlotINRA Centre de Versailles-Grignon, IJPB (UMR1318), Versailles Cedex, France.
Charles WhiteGénétique, Reproduction et Développement, UMR CNRS 6293, Clermont Université, INSERM U1103, Université Blaise Pascal, Clermont Ferrand, France.
Didier G SchaeferLaboratoire de Biologie Moléculaire et Cellulaire, Institut de Biologie, Université de Neuchâtel, Neuchâtel, Switzerland.
Fabien NoguéINRA Centre de Versailles-Grignon, IJPB (UMR1318), Versailles Cedex, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability to address the CRISPR-Cas9 nuclease complex to any target DNA using customizable single-guide RNAs has now permitted genome engineering in many species. Here, we report its first successful use in a nonvascular plant, the moss Physcomitrella patens. Single-guide RNAs (sgRNAs) were designed to target an endogenous reporter gene, PpAPT, whose inactivation confers resistance to 2-fluoroadenine. Transformation of moss protoplasts with these sgRNAs and the Cas9 coding sequence from Streptococcus pyogenes triggered mutagenesis at the PpAPT target in about 2% of the regenerated plants. Mainly, deletions were observed, most of them resulting from alternative end-joining (alt-EJ)-driven repair. We further demonstrate that, in the presence of a donor DNA sharing sequence homology with the PpAPT gene, most transgene integration events occur by homology-driven repair (HDR) at the target locus but also that Cas9-induced double-strand breaks are repaired with almost equal frequencies by mutagenic illegitimate recombination. Finally, we establish that a significant fraction of HDR-mediated gene targeting events (30%) is still possible in the absence of PpRAD51 protein, indicating that CRISPR-induced HDR is only partially mediated by the classical homologous recombination pathway.

Indexed as

CRISPR-Cas SystemsMutagenesisAdenineArabidopsis ProteinsBryopsidaClustered Regularly Interspaced Short Palindromic RepeatsDNA End-Joining RepairEndonucleasesGene TargetingGenetic EngineeringGenome, PlantHomologous RecombinationPlants, Genetically ModifiedProtoplastsRad51 RecombinaseSequence Deletion2-fluoroadenineAdenineArabidopsis ProteinsATRAD51 protein, ArabidopsisEndonucleasesRad51 Recombinasealt-EJCRISPR-Cas9gene targetinggenome editingPhyscomitrella patensRAD51

Identifiers

PMID27368642
PMCPMC5253467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.